-

Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 1:30 p.m. PT.

Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/

About Omnicell

Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics, smart devices, software, and expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit omnicell.com.

OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.

OMCL-E

Contacts

Kathleen Nemeth
Senior Vice President, Investor Relations
ir@omnicell.com

Omnicell, Inc.

NASDAQ:OMCL

Release Summary
Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Release Versions

Contacts

Kathleen Nemeth
Senior Vice President, Investor Relations
ir@omnicell.com

Social Media Profiles
More News From Omnicell, Inc.

Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer...

Omnicell Announces Chief Financial Officer Transition

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Chief Financial Officer Transition...

Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces Fiscal Year and Fourth Quarter 2024 Results...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.